Peng Pu

机构：Henan University of Science and Technology, Chinese Academy of Medical Sciences & Peking Union Medical College, The Affiliated Yongchuan Hospital of Chongqing Medical University, Chongqing Medical University · ORCID：0000-0003-0502-0513

发表论文 57 篇 · 总被引 1328 次 · h-index 16

代表论文

• Safety and effects of anti-obesity medications on weight loss, cardiometabolic, and psychological outcomes in people living with overweight or obesity: a systematic review and meta-analysis (2024 · EClinicalMedicine · 被引 55)
• Schisandrin B Antagonizes Cardiotoxicity Induced by Pirarubicin by Inhibiting Mitochondrial Permeability Transition Pore (mPTP) Opening and Decreasing Cardiomyocyte Apoptosis (2021 · Frontiers in Pharmacology · 被引 43)
• Efficacy, immunogenicity and safety of COVID-19 vaccines in older adults: a systematic review and meta-analysis (2022 · Frontiers in Immunology · 被引 37)
• Schisandrin B Diet Inhibits Oxidative Stress to Reduce Ferroptosis and Lipid Peroxidation to Prevent Pirarubicin‐Induced Hepatotoxicity (2022 · BioMed Research International · 被引 25)
• SETD7 promotes metastasis of triple-negative breast cancer by YY1 lysine methylation (2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 被引 20)
• Kaempferide improves oxidative stress and inflammation by inhibiting the TLR4/IκBα/NF-κB pathway in obese mice. (2021 · PubMed · 被引 15)